Product: Coniel^®（Benidipine Hydrochloride Tablets）

Indication: CONIEL^®is indicated for hypertension and Angina pectoris.

Product: NESP^®(darbepoetin α Injection)

Indication: For the treatment of anemia in adults with Chronic Kidney Disease ( CKD ) receiving hemodialysis.

Product: TAUROLITE^®(Tauroursodeoxycholic Acid Capsules)

Indication: Dissolution of cholesterol stones:

1. Presence of 1 or more cholesterol stones less than 2 cm in diameter visible on X-ray in the gallbladder or bile duct;

2. Refusal of surgical treatment or unsuitable for surgical treatment;

3. Cholesterol supersaturation confirmed by duodenal cannula bile test.

Product: Contractubex^®(Compound Heparin Sodium and Allantoin Gel)

Indication: Hypertrophic and keloidal scars, movement restricting and cosmetically disfiguring scars after operations, amputations, burns and accidents; contractures such as Dupuytren's contracture and traumatic tendon contracture, cicatricial strictures.

Product: Xenical^®(Orlistat Capsules)

Indication: This product combined with a low calorie diet is suitable for long-term treatment of obese and overweight people,including those who have obesity related risk factors.This product has long-term effect of weight control (weight loss, weight maintenance and prevention of weight rebound).Taking this product can reduce the incidence rate of obesity related risk factors and other obesity related diseases, including hypercholesterolemia, type 2 diabetes, impaired glucose tolerance, hyperinsulinemia, hypertension, and reduce the fat in organs.

Product: Xenical^®OTC(Orlistat Capsules)

Indication:Treatment of Obese or Overweight Patients (BMI > 24).

Product: Flivas^®(Naftopidil Tablets)

Indication:Flivas^® is indicated for the treatment of dysuria accompanying benign prostatic hyperplasia. Flivas^® improves the symptoms of difficulty in urination, nocturia, and incomplete emptying by decreasing urethral pressure.

Product: Glypressin^®(Terlipressin for Injection)

Indication: Glypressin^®is indicated in the treatment of bleeding esophageal varices.

Product: Hepa-Merz^®(Ornithine Aspartate Injection)

Indication: For the treatment of Hyperammonemia due to acute or chronic liver disease (e.g., all types of hepatitis, cirrhosis, fatty liver, post-hepatitis syndrome) and of hepatic encephalopathy, such as underlying or episodic hepatic encephalopathy with or secondary to impaired hepatic detoxification (e.g., cirrhosis), especially for the treatment of early hepatic coma or hepatic coma in a state of unconsciousness.